EMD-32036
Structure of recombinant RyR2 mutant K4593A (EGTA dataset)
EMD-32036
Single-particle3.3 Å

Map released: 10/08/2022
Last modified: 19/06/2024
Sample Organism:
Mus musculus,
Homo sapiens
Sample: Recombinant RyR2 mutant K4593A in the presence of EGTA
Fitted models: 7vmr (Avg. Q-score: 0.362)
Deposition Authors: Kobayashi T
,
Tsutsumi A
Sample: Recombinant RyR2 mutant K4593A in the presence of EGTA
Fitted models: 7vmr (Avg. Q-score: 0.362)
Deposition Authors: Kobayashi T


Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations.
Kobayashi T
,
Tsutsumi A
,
Kurebayashi N
,
Saito K,
Kodama M,
Sakurai T
,
Kikkawa M
,
Murayama T
,
Ogawa H
(2022) Nat Commun , 13 , 2821 - 2821







(2022) Nat Commun , 13 , 2821 - 2821
Abstract:
Cardiac ryanodine receptor (RyR2) is a large Ca2+ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca2+ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remains unknown. Here, we address the gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca2+ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.
Cardiac ryanodine receptor (RyR2) is a large Ca2+ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca2+ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remains unknown. Here, we address the gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca2+ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.